Allergen (AGN) Revenue Growth Plans Might Be Overly Ambitious
Tweet Send to a Friend
Jefferies today maintained a Hold rating on Allergen (NYSE: AGN) and raised its price target to $100.00 (from $95.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE